Navigation Links
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
Date:8/3/2009

humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products,
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Touro College has announced that it is supporting ... media marijuana licenses to be issued by the ... If CanniCare is selected, Touro would provide the ... college is supportive of medicinal development and research," said ... "There is still a great deal of research to be ...
(Date:7/29/2015)...  Henry Schein, Inc. (NASDAQ: HSIC ), ... and services to office-based dental, animal health and ... results. Net sales for the quarter ... increase of 0.5% compared with the second quarter ... local currencies and a 7.0% decline related to ...
(Date:7/29/2015)... CITY, Calif. , July 29, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... close on Monday, Aug 3rd, 2015. AcelRx management ... p.m. Eastern Time (1:30 p.m. Pacific Time) on ...
Breaking Medicine Technology:Touro College Announces Support for CanniCare's Medical Cannabis License Application 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4
(Date:7/29/2015)... ... 2015 , ... Toronto native Douglas James Cottrell, Ph.D., has ... been making predictions about the economy, politics, social issues, as well as the ... warns that extreme weather conditions and increased earthquake / volcanic activity will increase ...
(Date:7/29/2015)... ... 29, 2015 , ... " mybody ” was featured on NewsWatch as part ... businesses making an impact in their industry. Andrew Tropeano, the host of NewsWatch and ... skincare products are designed to strengthen the skin’s defense system from the inside out. ...
(Date:7/29/2015)... ... July 29, 2015 , ... National ... provider of life insurance, annuities, employee benefits and asset management, has joined as ... sporting event taking place in Charlotte, North Carolina on October 2-4, 2015. , ...
(Date:7/29/2015)... , ... July 29, 2015 , ... People that are ... two new products on Mercola.com: a vertical “garden tower” and enhanced mineral product for ... squeezed into small corners on a porch, balcony, or rooftop – can hold up ...
(Date:7/29/2015)... DC (PRWEB) , ... July 29, 2015 , ... ... aluminum-related illnesses is seeking funding for a study on the potentially lifesaving impact ... Research Institute today . , The research proposal is based on a ...
Breaking Medicine News(10 mins):Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... to researchers, chemotherapy brings about long lasting modifications in ... responsible// for the mental fog and confusion in several ... researchers at the University of California, Los Angeles, revealed ... cortex in women who had undergone chemotherapy 5-10 years ...
... from over in Bihar with the detection of new cases ... immunisation drive this year//. ,Eight districts of Magadh and ... cases were detected in Jehanand, while one each came up ... new cases of polio, an official said. ,Keeping the ...
... daily physical exercise for their future good health, says a ... children at 36 nurseries in Glasgow. ,The researchers ... exercise - 30 minutes, three times a week, reported the ... was not enough to affect the children's body mass index ...
... experts, some cancer patients are experiencing unjust dismissal and ... legislation to protect their rights//. ,The Disability ... last year has provided effective protection at work to ... the Disability Rights Commission (DRC) has reported that 200 ...
... has received a shot in the arm by way of ... have found that Aspirin is endowed with the potential to ... the bud. Indeed, this information may throw open a plethora ... Dr Helen Arthur of Newcastle University, previous research has indicated ...
... patients with schizophrenia whose medication is changed because ... drugs do not appear to offer significant benefits ... report in the October issue of Archives of ... ,The findings run contrary to the widely ...
Cached Medicine News:Health News:Chemotherapy causes mental fog 2Health News:Injustice to cancer patients at work 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 3
Shandon Paraffin Block Cartons...
... histological embedment block cataloging ... file system incorporates the ... block protection, simplified cataloging, ... and facilitation of retrieval. ...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: